Kainos Medicine, Inc. (KOSDAQ:284620)
South Korea · Delayed Price · Currency is KRW 1,087.00
-105.00 (-8.81%)
At close: Aug 14, 2025
Kainos Medicine Market Cap
Kainos Medicine has a market cap or net worth of 35.56 billion as of January 30, 2026. Its market cap has decreased by -69.37% in one year.
Market Cap
35.56B
Enterprise Value
37.38B
Revenue
938.87M
Ranking
n/a
PE Ratio
n/a
Stock Price
1,087.00
Market Cap Chart
Since June 9, 2020, Kainos Medicine's market cap has decreased from 434.22B to 35.56B, a decrease of -91.81%. That is a compound annual growth rate of -38.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2025 | 35.56B | -60.20% |
| Dec 30, 2024 | 89.33B | -25.94% |
| Dec 28, 2023 | 120.62B | 5.37% |
| Dec 29, 2022 | 114.48B | -59.11% |
| Dec 30, 2021 | 279.94B | -40.72% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EyeGene | 67.22B |
| MOA Life Plus | 63.52B |
| NGeneBio | 50.45B |
| J2KBIO | 49.65B |
| Aptamer Sciences | 47.42B |
| SCM Lifescience | 36.42B |
| Epibiotech | 34.33B |
| ADBiotech | 30.35B |